Miro Venturi
Director/Board Member at Tethis SpA
Profile
Miro Venturi is one of LongeVC's Advisory Board members.
He is an enthusiastic professional with extensive experience in the pharmaceutical sector.
In 2002, Miro joined the pharmaceutical industry as a Biomarker Laboratory Head and project team representative at Pharmacia Corp (later Pfizer Inc.) at the Oncology R&D site.
In this role, he established the biomarker laboratories and actively contributed to developing numerous oncology programs focusing on small molecular weight kinase inhibitors.
In 2005, Miro was invited to join the University "Vita Salute San Raffaele" faculty in Milan as an Adjunct Professor of preclinical and early clinical development of biopharmaceuticals.
Later, in 2007, Miro moved to Novartis as its Divisional Head in Biomarker Development, supervising a team of scientists developing assays and supporting project teams to realise personalised medicine strategies across the portfolio.
Miro has contributed to several drug research and scientific development projects and published in relevant scientific journals, including Nature, Cell, and PNAS.
Currently, Miro is an Advisory Committee Member of Bios+ Bellinzona Institute of Sciences and a Board Member of Sintetica SA - Innovating Therapies
Miro holds a Master's degree in Biochemistry from Alma Mater Studiorum, Università di Bologna, and a PhD in Biochemistry - Molecular Biophysics from Goethe University.
His Post Doctorate is in Vaccine Design - Structural Biology - Molecular Virology from the National Institutes of Health.
Miro Venturi active positions
| Companies | Position | Start |
|---|---|---|
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Director/Board Member | 19/07/2021 |
Novigenix SA
 Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Director/Board Member | 01/08/2021 |
LongeVC
 LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Consultant / Advisor | - |
Former positions of Miro Venturi
| Companies | Position | End |
|---|---|---|
Sintetica SA
 Sintetica SA Pharmaceuticals: MajorHealth Technology Sintetica SA operates as a pharmaceutical company that provides injectable anaesthetics and analgesics. The company was founded in 1921 and is headquartered in Mendrisio, Swizerland. | Chief Executive Officer | 01/04/2023 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Director/Board Member | 31/12/2020 |
| FOUNDATION MEDICINE INC | President | 30/10/2020 |
CellPly SRL
 CellPly SRL Medical SpecialtiesHealth Technology CellPly SRL develops and markets customized diagnostic tools for cancer treatment. The firm specializes in the design and marketing of solutions for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. It offers a platform that analyzes ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. The firm focuses on helping oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification. The company was founded by Massimo Bocchi and Roberto Guerrieri in 2013 and is headquartered in Bologna, Italy. | Consultant / Advisor | 31/10/2019 |
Nerviano Medical Sciences SRL
 Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Corporate Officer/Principal | 01/03/2008 |
Training of Miro Venturi
| Alma Mater Studiorum - Università di Bologna | Graduate Degree |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Nerviano Medical Sciences SRL
Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Health Technology |
Sintetica SA
Sintetica SA Pharmaceuticals: MajorHealth Technology Sintetica SA operates as a pharmaceutical company that provides injectable anaesthetics and analgesics. The company was founded in 1921 and is headquartered in Mendrisio, Swizerland. | Health Technology |
CellPly SRL
CellPly SRL Medical SpecialtiesHealth Technology CellPly SRL develops and markets customized diagnostic tools for cancer treatment. The firm specializes in the design and marketing of solutions for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. It offers a platform that analyzes ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. The firm focuses on helping oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification. The company was founded by Massimo Bocchi and Roberto Guerrieri in 2013 and is headquartered in Bologna, Italy. | Health Technology |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Health Technology |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Finance |
- Stock Market
- Insiders
- Miro Venturi
